Legionella hackeliae is one of 22 species in the genus Legionella (1) . The type strain of the species, Lansing 2, was isolated from a bronchial biopsy specimen from a patient with pneumonia. We report here on a second serogroup of L. hackeliae isolated from a lung aspirate from an immunocompromised woman with pneumonia.
CASE REPORT
A 52-year old woman was admitted to Montefiore Hospital in March 1982 for an unidentified illness, which included fever and diffuse lymphadenopathy. One month before, she had required endotracheal intubation for congestive heart failure and, during that time, had been placed on 20 mg of prednisone per day for treatment of hypereosinophilia with pulmonary infiltrates. During the present admission, although she was asymptomatic, a new left-upper-lobe infiltrate was found on a chest x ray. A biopsy of an enlarged cervical lymph node revealed immunoblastic lymphadenopathy with transformation to immunoblastic sarcoma. A gram stain of material obtained from a percutaneous lung aspirate of the left upper lobe revealed numerous polymorphonuclear leukocytes and small gram-negative rods. A modified Kinyoun stain was negative, as were direct immunofluorescence assays (DFA) (2) for L. pneumophila serogroups 1 to 6, L. micdadei, L. dumoffii, L. bozemanii, L. gormanii, and both serogroups of L. longbeachae. After the biopsy, the patient was started on cefamandole (1 g every 6 h). Her fever abated and, after 10 days, the antibiotic was discontinued. She was discharged 5 days later. Subsequently, a Legionella-like organism not reactive with any available anti-Legionella conjugate was grown from the lung aspirate material on buffered charcoalyeast extract (BCYE) agar. Cultures for routine aerobic and anaerobic bacteria, mycobacteria, and fungi were negative. Follow-up chest x rays over the next 3 months disclosed gradual resolution of the pulmonary infiltrate.
MATERIALS AND METHODS
The Legionella-like organism 798-PA-H was sent to the Immunology Section, Centers for Disease Control, for further characterization. The organism was inoculated onto BCYE agar, BCYE agar without cysteine, and blood agar as previously described (4) . The strain was tested with working * Corresponding author.
dilutions of all available DFA conjugates (2): L. pneumophila serogroups 1 to 9 and strains Seattle 1 and San Francisco 9, L. longbeachae serogroups 1 and 2, L. bozemanii serogroup
spiritensis, L. hackeliae, L. jordanis, and L. rubrilucens. Antisera to all known Legionella species (n = 22) and serogroups (n = 34) were used in the slide agglutination test (2a, 3) . Antisera to strain 798-PA-H were prepared, and cross-absorption experiments were performed as previously described (3). Gas-liquid chromatography was performed by William R. Mayberry, East Tennessee State University, Johnson City. DNA hybridization and physiologic studies were performed as previously described (1) .
RESULTS
The organism grew on BCYE agar but not on BCYE agar without cysteine or on blood agar. By DFA, strain 798-PA-H stained minimally ( Reciprocal absorption studies with the Lansing 2 and 798-PA-H antisera and strains showed that cross-reactive antibodies could be removed by absorption with the heterologous strain without removing antibodies to the homologous strain (Table 1) . This supports the designation of 798-PA-H (ATCC 35999) as a second serogroup of L. hackeliae. [11] ). The remaining 10 species were isolated from environmental specimens.
The large number of antisera required to identify all known legionellae has made DFA staining with monospecific conjugates impractical. Isolation of the organism should always be attempted. This is especially important in identifying Legionella-like organisms that do not react or that react minimally with antisera to presently known species or serogroups. In the present study, a specific diagnosis of the pneumonia and demonstration of L. ha-ckeliae serogroup 2 as the etiologic agent were possible only after the organism had been isolated.
